Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0003000 Exon-Exon chr12:120572337-120613015 chr12:120134533-120175212 250 nt 0.4440
hsa_GCN1L1_0003100 Exon-Exon chr12:120572337-120614020 chr12:120134533-120176217 250 nt 0.4400
hsa_GCN1L1_0003300 Exon-Exon chr12:120574306-120608125 chr12:120136502-120170321 250 nt 0.4680
hsa_GCN1L1_0003600 Exon-Exon chr12:120575010-120585076 chr12:120137206-120147272 2051 nt 0.5680
hsa_GCN1L1_0003700 Exon-Exon chr12:120575349-120602525 chr12:120137545-120164721 250 nt 0.4560
hsa_GCN1L1_0003800 Exon-Exon chr12:120575349-120615358 chr12:120137545-120177555 250 nt 0.4400
hsa_GCN1L1_0003900 Exon-Exon chr12:120575705-120580745 chr12:120137901-120142941 898 nt 0.5657
hsa_GCN1L1_0004000 Exon-Exon chr12:120575705-120615358 chr12:120137901-120177555 250 nt 0.4440
hsa_GCN1L1_0004100 Exon-Exon chr12:120576127-120582639 chr12:120138323-120144835 1094 nt 0.5530
hsa_GCN1L1_0004200 Exon-Exon chr12:120576127-120585076 chr12:120138323-120147272 1523 nt 0.5640
Showing 21 to 30 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].